Chemokinome characterization in human lung macrophages following stimulation with Th2-type cytokines IL-4 or IL-13
Stanislas Grassin‐Delyle, Amparo Buenestado, Charlotte Abrial, Marion Brollo, Emmanuel Naline, Philippe Devillier
Abstract
Stanislas Grassin‐Delyle, Amparo Buenestado, Charlotte Abrial, Marion Brollo, Emmanuel Naline, Philippe Devillier
Abstract
Background: Macrophages may acquire polarized phenotypes, the two extremes being the proinflammatory (M1) and immunoregulatory (M2) phenotypes characterized by surface markers and chemokinome profiles. Reprogramming of AM toward a partially M2-polarized phenotype has been suggested to contribute to COPD pathogenesis. We thus sought to characterize the phenotype of human lung macrophages (LM) following stimulation with the Th2-type cytokines IL-4 and IL-13. Methods: LM were isolated from human resected lungs challenged for 24 or 48hrs with IL-4 or IL-13 (1-150 ng/mL). Cytokines transcript expression was assessed with RT-qPCR, whereas proteins of M1 (TNF-α, CCL3, CCL4 and CXCL8) and M2 cytokines (CCL13, CCL17 and CCL22) were quantified in supernatants. Results: Unstimulated LM exhibited a rather undifferenciated phenotype, with weak M1/M2 cytokines expression. On the other hand, transcriptome analysis of 80 cytokines gene revealed that only four M2-type transcripts levels were increased (4- to 8-fold) following stimulation with IL-13 (CCL13, CCL17, CCL22 and CCL26). M2-type cytokine production at the protein level was also concentration-dependently increased (3- to 20-fold), whereas M1 cytokines were unaffected. CCL13 and CCL22 increase was maximal at 48hrs, while the maximum was reached at 24hrs for CCL17. The results obtained with IL-4 were similar, except that IL-4 potency was greater than IL-13 since the low 10 ng/mL concentration provided submaximal cytokines increases. Conclusions: Our data demonstrate that IL-4 and IL-13 favours LM polarization toward the immunoregulatory M2 phenotype characterized by the expression of CCL13, CCL17, CCL22 and CCL26.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Background: Macrophages may acquire polarized phenotypes, the two extremes being the proinflammatory (M1) and immunoregulatory (M2) phenotypes characterized by surface markers and chemokinome profiles. Reprogramming of AM toward a partially M2-polarized phenotype has been suggested to contribute to COPD pathogenesis. We thus sought to characterize the phenotype of human lung macrophages (LM) following stimulation with the Th2-type cytokines IL-4 and IL-13. Methods: LM were isolated from human resected lungs challenged for 24 or 48hrs with IL-4 or IL-13 (1-150 ng/mL). Cytokines transcript expression was assessed with RT-qPCR, whereas proteins of M1 (TNF-α, CCL3, CCL4 and CXCL8) and M2 cytokines (CCL13, CCL17 and CCL22) were quantified in supernatants. Results: Unstimulated LM exhibited a rather undifferenciated phenotype, with weak M1/M2 cytokines expression. On the other hand, transcriptome analysis of 80 cytokines gene revealed that only four M2-type transcripts levels were increased (4- to 8-fold) following stimulation with IL-13 (CCL13, CCL17, CCL22 and CCL26). M2-type cytokine production at the protein level was also concentration-dependently increased (3- to 20-fold), whereas M1 cytokines were unaffected. CCL13 and CCL22 increase was maximal at 48hrs, while the maximum was reached at 24hrs for CCL17. The results obtained with IL-4 were similar, except that IL-4 potency was greater than IL-13 since the low 10 ng/mL concentration provided submaximal cytokines increases. Conclusions: Our data demonstrate that IL-4 and IL-13 favours LM polarization toward the immunoregulatory M2 phenotype characterized by the expression of CCL13, CCL17, CCL22 and CCL26.
Key concepts: Proinflammatory cytokine, CCL17, CCL13, Chemokine, CCL22, Cytokine, Medicine, CXCL2